SEED PHARMA CARBIMAZOLE 5 carbimazole 5 mg tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

seed pharma carbimazole 5 carbimazole 5 mg tablet blister pack

seed pharma pty ltd - carbimazole, quantity: 5 mg - tablet - excipient ingredients: croscarmellose sodium; lactose; magnesium stearate - therapy of hyperthyroidism. definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. preparation for thyroidectomy. before and after radioactive iodine treatment.

LEVOXINE levothyroxine sodium 200 micrograms tablet bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

levoxine levothyroxine sodium 200 micrograms tablet bottle

sun pharma anz pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet - excipient ingredients: magnesium stearate; pregelatinised starch; microcrystalline cellulose; hyprolose; allura red ac aluminium lake - levothyroxine sodium is indicated for the management of demonstrated thyroid hormone deficiency.,levothyroxine sodium is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHOX levothyroxine sodium 50 microgram tablet bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

levothox levothyroxine sodium 50 microgram tablet bottle

accord healthcare pty ltd - levothyroxine sodium, quantity: 50 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; sodium stearylfumarate; microcrystalline cellulose; light magnesium oxide - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHOX levothyroxine sodium 200 microgram tablet bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

levothox levothyroxine sodium 200 microgram tablet bottle

accord healthcare pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium starch glycollate; sodium stearylfumarate; microcrystalline cellulose; allura red ac aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHOX levothyroxine sodium 100 microgram tablet bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

levothox levothyroxine sodium 100 microgram tablet bottle

accord healthcare pty ltd - levothyroxine sodium, quantity: 100 microgram - tablet, uncoated - excipient ingredients: sodium starch glycollate; light magnesium oxide; microcrystalline cellulose; sodium stearylfumarate; sunset yellow fcf aluminium lake; tartrazine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHOX levothyroxine sodium 75 microgram tablet bottle 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

levothox levothyroxine sodium 75 microgram tablet bottle

accord healthcare pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet, uncoated - excipient ingredients: light magnesium oxide; sodium stearylfumarate; sodium starch glycollate; microcrystalline cellulose; allura red ac aluminium lake; indigo carmine aluminium lake - levothox is indicated for the management of demonstrated thyroid hormone deficiency.,levothox is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 200 microgram un-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 200 microgram un-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 200 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.2 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

APO-LEVOTHYROXINE levothyroxine sodium 150 microgram un-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

apo-levothyroxine levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

LEVOTHYROXINE LUP levothyroxine sodium 150 microgram un-coated tablet blister pack 澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

levothyroxine lup levothyroxine sodium 150 microgram un-coated tablet blister pack

southern cross pharma pty ltd - levothyroxine sodium, quantity: 0.15 mg - tablet, uncoated - excipient ingredients: maize starch; gelatin; croscarmellose sodium; magnesium stearate; lactose monohydrate - indicated for the management of demonstrated thyroid hormone deficiency. and also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.